Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice

Abstract

Fusion proteins created by chromosomal abnormalities are key components of mesenchymal cancer development. The most common chromosomal translocation in liposarcomas, t(12;16)(q13;p11), creates the FUS–CHOP fusion gene. In the past, we generated FUS–CHOP and CHOP transgenic mice and have shown that while FUS–CHOP transgenic develop liposarcomas, mice expressing CHOP, which lacks the FUS domain, display essentially normal white adipose tissue (WAT) development, suggesting that the FUS domain of FUS–CHOP plays a specific and critical role in the pathogenesis of liposarcoma. To test the significance of FUS and CHOP domain interactions within a living mouse, we generated mice expressing the FUS domain and crossed them with CHOP-transgenic mice to generate double-transgenic FUSxCHOP animals. Here we report that expression of the FUS domain restores liposarcoma development in CHOP-transgenic mice. Our results provide genetic evidence that FUS and CHOP domains function in trans for the mutual restoration of liposarcoma. These results identify a new mechanism of tumor-associated fusion genes and might have impact beyond myxoid liposarcoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Aman P, Panagopoulos I, Lassen C, Fioretos T, Mencinger M, Toresson H, Hoglund M, Forster A, Rabbitts TH, Ron D, Mandahl N, Mitelman F . 1996 Genomics 37: 1–8

  • Batchvarova N, Wang XZ, Ron D . 1995 EMBO J. 14: 4654–4661

  • Carlson SG, Fawcett TW, Bartlett JD, Bernier M, Holbrook NJ . 1993 Mol. Cell. Biol. 13: 4736–4744

  • Castellanos A, Pintado B, Wuruaga E, Arévalo R, López A, Orfao A, Sánchez-García I . 1997 Blood 90: 2168–2174

  • Chang HR, Hajdu SI, Collin C, Brennan MP . 1989 Cancer 64: 1514–1520

  • Crozat A, Aman P, Mandahl N, Ron D . 1993 Nature 363: 640–644

  • Fornace Jr AJ, Nebert DW, Hollander MC-, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook N-J . 1989 Mol. Cell. Biol. 9: 4196–4203

  • Ichikawa H, Shimizu K, Hayashi Y, Ohki M . 1994 Cancer Res. 54: 2865–2868

  • Knight JC, Renwick PJ, Cin PD, Van den Berghe H, Fletcher CD . 1995 Cancer Res. 55: 24–27

  • Mack TM . 1995 Cancer 75: 211–244

  • Mizushima S, Nagata S . 1990 Nucleic Acids Res. 18: 4322–

  • Panagopoulos I, Aman P, Fioretos T, Höghind M, Johansson B, Mandahl N, Heim S, Behrendtz M, Mitelman F . 1994 Genes Chrom. Cancer 11: 256–262

  • Panagopoulos I, Mandahl N, Mitelman F, Aman P . 1995 Oncogene 11: 1133–1137

  • Pérez-Losada J, Pintado B, Gutiérrez-Adán A, Flores T, Bañares-González B, Calabia del Campo J, Martín-Martín JF, Battaner E, Sánchez-García I . 2000a Oncogene 19: 2413–2422

  • Pérez-Losada J, Sánchez-Martín M, Rodríguez-García MA, Pérez-Mancera PA, Pintado B, Flores T, Battaner E, Sánchez-García I . 2000b Oncogene 19: 6015–6022

  • Prasad DD, Ouchida M, Lee L, Rao VN, Peddy ESP . 1994 Oncogene 9: 3717–3729

  • Price BD, Calderwood SK . 1992 Cancer Res. 52: 3814–3817

  • Rabbitts TH, Forster A, Larson R, Nathan P . 1993 Nature Genet. 4: 175–180

  • Ron D, Habener JF . 1992 Genes Dev. 6: 439–453

  • Sánchez-García I, Rabbitts TH . 1994 Proc. Natl. Acad. Sci. USA 91: 7869–7873

  • Sánchez-García I . 1997 Annu. Rev. Genetics 31: 429–453

  • Shimizu K, Ichikawa H, Tojo A, Kaneko Y, Maseki N et al. 1993 Proc. Natl. Acad. Sci. USA 90: 10280–10284

  • Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CDM, Brun RP, Mueller E, Altiok S, oppenheim H, Evans RM, Spiegelman BM . 1997 Proc. Natl. Acad. Sci. USA 94: 237–241

  • Wang XZ, Lawson B, Brewer JW, Zinszner H, Sanjay A, Mi LJ, Boorstein R, Kreibich G, Hendershot LM, Ron D . 1996 Mol. Cell. Biol. 16: 4273–4280

  • Zinszner H, Albalat R, Ron D . 1994 Genes Dev. 8: 2513–2526

Download references

Acknowledgements

We are grateful to JC Villoria-Terrón for excellent technical assistance with mice. We are indebted to members of lab 13 for helpful discussions, and specific thanks to Prof R González-Sarmiento for his unconditional help and support. This work has been supported by DGCYT (1FD97-0360, SAF2000-0148, BIO2000-0453-P4-02 and 1FD97-1126), Fundación Científica of the AECC, Junta de Castilla y León (C.S.12/99 and C.S.I. 3/01), FIS (99/0935 and 01/0114), and NIH grant (1 R01 CA79955-01). PA Pérez-Mancera and MA Rodríguez-García are scholarship holders from MEC and CSIC-GLAXO, respectively.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isidro Sánchez-García.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pérez-Mancera, P., Pérez-Losada, J., Sánchez-Martín, M. et al. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice. Oncogene 21, 1679–1684 (2002). https://doi.org/10.1038/sj.onc.1205220

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205220

Keywords

This article is cited by

Search

Quick links